Last reviewed · How we verify
Indapamide and chlorthalidone to reduce urine supersaturation for kidney stone prevention
Approved treatments
Pipeline
- CHLORTHALIDONE — Phase 2
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Indapamide and chlorthalidone to reduce urine supersaturation for kidney stone prevention patent landscape — cliff calendar, originator estates, attackable patents
- Indapamide and chlorthalidone to reduce urine supersaturation for kidney stone prevention treatment landscape brief
- Indapamide and chlorthalidone to reduce urine supersaturation for kidney stone prevention treatment updates RSS
Frequently asked questions about Indapamide and chlorthalidone to reduce urine supersaturation for kidney stone prevention
What new drugs are in development for Indapamide and chlorthalidone to reduce urine supersaturation for kidney stone prevention?
1 pipeline drugs tracked. Top candidates: CHLORTHALIDONE.
Related
- Treatment landscape: Indapamide and chlorthalidone to reduce urine supersaturation for kidney stone prevention patent cliff · Indapamide and chlorthalidone to reduce urine supersaturation for kidney stone prevention CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing